Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Clinical trial NCT07207408 · RECRUITING

Trial details

NCT number: NCT07207408
Sponsor: Dynavax Technologies Corporation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis

Start date: 2025-09-11
Primary completion: 2027-01-29
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.